Back to Results
First PageMeta Content
Johnson & Johnson / Dow Jones Industrial Average / Pharmaceuticals policy / Centocor / Alza / Tibotec / Pharmaceutical industry / Duragesic / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Health


Open Document

File Size: 2,25 MB

Share Result on Facebook

City

Cashel / /

Company

Principal Global Affiliates / Ortho-McNeil Pharmaceutical / Tibotec-Virco N.V. / DePuy / McNeil Consumer & Specialty Pharmaceuticals / ALZA / Cashel / IPR&D / OraPharma Inc. / Centocor Inc. / Obtech Medical AG / Ortho-Clinical Diagnostics / Johnson & Johnson / Hepatitis C. Virco / Dimensional Pharmaceuticals / Scios Inc. / Tanabe Seiyaku Ltd. / /

Continent

Europe / Asia / /

Country

Japan / Belgium / United States / Ireland / /

Currency

USD / /

Event

Dividend Issuance / Company Expansion / Product Release / M&A / FDA Phase / Employment Change / Reorganization / /

Facility

facility of Centocor / Cashel plant / Cashel facility / /

IndustryTerm

manufacturing facility / pharmaceutical segments / prevention of migraine / pharmaceutical agents / pharmaceutical businesses / surgical sports medicine / pharmaceutical sales / surgery products / technology infrastructure / health products / diagnostic tools / manufacturing center / monoclonal antibody manufacturing facility / technology plat / disease management tools / treatment of attention deficit hyperactivity disorder / delivery technology / product solutions / pharmaceutical tablet / clinical management / smart technologies / pharmaceutical / diagnostic products / pharmaceutical superior returns / health care products / manufacturer / biopharmaceutical / drug delivery technology / treatment of HIV / consumer products / prescription products / drug delivery technologies / circulatory disease management products / technology-based products / /

MedicalCondition

HIV / arthritis / severe Crohn’s disease / chronic renal failure / rheumatoid arthritis / al pneumonia / enhancements infection / U.S. Food obesity / innovative disease / monotherapy treatment cal site infection / ADHD / cancer / chronic acceptance / attention deficit hyperactivity disorder / viral infections / migraine headaches / peptic ulcers / Pure Red Cell Aplasia / gastrointestinal disorders / congestive heart failure / disease / Cordis circulatory disease / Crohn’s disease / Great Depression / pain / infectious diseases / testinal reflux disease / anemia / predialysis kidney disease / /

MedicalTreatment

biologic therapy / Surgery / elective surgeries / dialysis / drug delivery system / chemotherapy / invasive surgery / AID / /

MusicGroup

Board of Directors / /

Organization

Medicare / Drug Administration / National Center for Primary Care / Morehouse School of Medicine / /

Person

Joyce Salpan / Julio Alvarez / Koen Van Acker / Robert Strickland / Paula McKenna / Maxine Singer / Gery Dams / David Satcher / Robert Wilson / John Snow / William C. Weldon / /

Position

director / diagnostic lab operations / Chairman and Chief Executive Officer / Senior Vice Chairman of the Board / General / managing director / Singer / a member of the Board / Surgeon / Independent Auditor / counsel / United James T. Lenehan Vice Chairman of the Board and President / manager / Secretary of the Treasury of the United States / market leader / Vice Chairman and President / Director / senior supervisor / senior scientist / opportunities Chief Executive Officer / Chairman of the Board / member of the Board / /

Product

DURAGESIC / RISPERDAL / REMICADE / CONCERTA / ORTHO TRI-CYCLEN / TOPAMAX / EPREX / ACIPHEX / ORTHO EVRA / LEVAQUIN / VICRYL® Plus / OF TECHNOLOGY REMICADE® (infliximab) / PARIET® / /

ProvinceOrState

California / McNeil / Pennsylvania / /

Region

Latin America / /

Technology

pharmacogenomic / anti-infectives / drug discovery / chemotherapy / drug delivery system / Customer Relationship Management technologies / dialysis / free cash Technology / diagnostic tools / sports medicine / delivery technology / drug delivery technology / drug delivery technologies / 2003 DELIVERING ON THE PROMISE OF TECHNOLOGY / 6 DELIVERING ON THE PROMISE OF TECHNOLOGY / drug design / /

SocialTag